12:00 AM
May 17, 2010
 |  BC Week In Review  |  Company News  |  Deals

Dong-A Pharmaceutical, GlaxoSmithKline deal

GlaxoSmithKline acquired a 9.9% stake in Dong-A as part of a deal in which the companies partnered to co-promote their primary care products in...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >